EAM Investors, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$2,466,658
-32.1%
155,429
-19.3%
0.48%
-29.3%
Q2 2023$3,632,834
-8.0%
192,519
-48.7%
0.67%
+2.4%
Q1 2018$3,947,000
-12.7%
375,205
-36.5%
0.66%
+9.3%
Q3 2017$4,519,000
+9.0%
590,708
+1.3%
0.60%
-12.3%
Q2 2017$4,144,000582,8650.68%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders